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Abstract
An atom-economical purification protocol, using solution phase processing via ring-opening
metathesis polymerization (ROMP) has been developed for the synthesis of tricyclic sultams. This
chromatography-free method allows for convenient isolation of reductive-Heck products and
reclamation of excess starting material via sequestration involving metathesis catalysts and a
catalyst-armed Si-surface.
The growing need for new pharmaceutical leads has prompted advances in high-throughput
screening and the development of emerging synthetic methods and technologies.1 In this
regard, access to novel heterocyclic scaffolds in a minimal number of steps is a key facet of
drug discovery. Among these, the integration of synthesis and purification has enabled
seminal advances in both combinatorial and parallel synthetic chemistry.2 Conventionally,
this goal has been achieved by operating on resin-bound substrates with excess reagents or
treating solution phase substrates with excess immobilized reagents.3 Both scenarios,
although not optimal in terms of atom economy, have been extensively represented in the
literature. Though rarely used, a third scenario employs the use of excess substrate, normally
considered the precious component. However, if excess substrate is warranted and can be
further processed in a parallel reaction, i.e., “reclaimed”, this unfavorable scenario can be
advantageous. We herein report a new chromatography-free method in the context of
complex sultam synthesis,4,5 which allows for convenient isolation of reductive-Heck
products and reclamation of excess starting material via sequestration involving metathesis
catalysts and catalyst-armed SiO2 surface.
Previously, the synthesis of a diverse collection of sultams derived from a core
intramolecular Diels–Alder (IMDA) scaffold 1 via a metathesis cascade protocol was
reported.6 In this approach, the core scaffold that is readily synthesized on gram-scale
utilizing a report by Metz and coworkers,7 undergoes a ring-opening, ring-closing, cross-
metathesis (ROM-RC-CM) protocol with a variety of CM partners in a one-pot
transformation. Building on this work, additional pathways for the diversification of this
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core scaffold were investigated. In this regard, sultam 1 was subjected to the reductive Heck
reaction using Pd(OAc)2, Zn and excess aryl coupling partner (1.5 equiv.) to push the
reaction to completion.8 Despite the use of excess aryl iodide (4MeO-PhI), the reaction
proceeded in good yield (60%) with excellent regio-and diastereoselectivity (>19: 1).
However, it was found that purification of the crude reaction mixture via standard
chromatographic purification was very tedious due to the close similarity in Rf between the
desired product 2a and the remaining starting material 1 (Scheme 1). Though markedly low
product yield was easily improved through the use of excess scaffold 1 (1.5 equiv.),
purification restricted the method’s application to high-throughput generation of sultam
derivatives 2.9 To address this issue, it was envisioned that the remaining starting material 1,
possessing an oxa-norbor-nene motif (“armed scaffold”), could be removed via exposure to
metathesis catalyst and phase-trafficking through ring-opening metathesis polymerization
(ROMP) to generate the corresponding oligomeric scaffold 3.10,11 Simple precipitation of
the oligomer would allow for rapid isolation of desired product and recovery of oligomer in
an atom economic approach (Scheme 2).
With the aforementioned goal in mind, initial investigation focused on sultam 1 (1.5 equiv.)
which underwent reductive Heck reaction with 4-MeO-PhI (1 equiv.) in the presence of
Pd(OAc)2 and Zn in DMF at 60 °C. After completion of the reaction, the mixture was
filtered through Celite (to remove Zn), concentrated, and subjected to ROM polymerization
using Grubbs catalyst [(IMesH2)(PCy3)(Cl)2Ru = CHPh, cat-B],12 where simple
precipitation and filtration afforded the corresponding reductive Heck sultam 2a in 82%
yield and >95% crude purity (Table 1, entry 1). With the successful application of this
reductive-Heck, metathesis-sequestration protocol, nine aryl iodides were further
successfully utilized (Table 1, entry 2–10).
Despite the success of this protocol, the required precipitation of each reaction was not ideal
from a high throughput standpoint. In order to address this issue, the utilization of a catalyst-
armed surface, generated from norbornenyl-tagged (Nb-tagged) silica particles,13,14 was
investigated. Purification required simple filtration rather than the use of additional solvent
to precipitate the spent oligomer. Sultam 4 was subjected to standard reductive-Heck
conditions, and upon completion, the crude mixture was cannulated into a reaction vessel
containing “pre-armed” Nb-tagged Si-particles. After heating for 30 min–1 h (TLC
monitoring), the crude reaction mixture was filtered through a Celite® SPE to yield the
desired product 5a–b in good yield and crude purity (Scheme 3).
With the successful application of the reductive-Heck-metathesis sequestration protocol, we
investigated the utilization of the reclaimed oligomerized scaffold 3 isolated after
purification. To this effect, oligomer 3 was subjected to reductive ozonolysis15 generating
diol intermediate 6, which underwent cyclization with ROMP-derived oligomeric sulfonyl
chloride (OSC)16 to yield the corresponding polyether 7 without the need for purification
(Scheme 4).
Oligomer 3 could also be readily converted into oligomer 8 without the need for standard
purification. Diversification and subsequent release off the oligomer via Barrett’s vanishing
support17 protocol was readily achieved in a 3-step Suzuki,18 reductive ozonolysis
procedure to yield the corresponding diols 9a–d in good overall yield and excellent purities.
Overall, this approach offers several advantages, including: (i) atom economy, where the
oligomer (i.e. reclaimed scaffold) is converted to alternative small molecules after
degradation; (ii) elimination of the need for an additional linker (in contrast to traditional
SPOC); and (iii) parallel processing with minimal waste stream.
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In conclusion, an atom-economical protocol utilizing ROM polymerization has been
developed. This chromatography-free method allows for convenient isolation of reductive-
Heck products and reclamation of excess oligomeric sultam scaffold via precipitation. Using
solution phase processing, the recovered oligomeric scaffold is readily transformed into an
array of new, skeletally diverse sultam scaffolds via a vanishing support protocol.17
Application of this method to an array of norbor-nene-type scaffolds is in progress and will
be reported in due course.
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Reductive Heck diversification of 1 utilizing excess reagent.
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Reductive Heck diversification of 1 utilizing excess scaffold 1.
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Sequestration of excess SM 4 via catalyst-armed Si-particles.
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Diversification-release of corresponding derived-sultams from reclaimed oligomer 3.
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Table 1
Reductive Heck, followed by ROMP sequestration
Entry R1 Yield (%) Purity %a Comp.
1 p-CH3O–Ph 82 >95 2a
2 p-F–Ph 77 >95 2b
3 p-CO2CH3–Ph 86 >95 2c
4 p-OH–Ph 89 >95 2d
5 m-F–Ph 82 >95 2e
6 3,5 di-CH3–Ph 76 >95 2f
7 p-CH3–Ph 75b >95 2g
8 2-thiophene–Ph 81b >95 2h
9 p-CF3O–Ph 73c >95 2i
10 p-CN–Ph 65c >95 2j
a
Purity determined by 1H NMR,
b
dr = 3:1 determined by 1H NMR,
c
dr = 4:1 determined by 1H NMR.
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